@MSIMaker Thought you might be interested...
https://unauthorised investment advice/health/gold-coast-investment-showcase-wrap-day-2/amp/
Neuroscientific Biopharma non-executive chairman Brian Leedman championed the Alzheimer’s-fighting drug the company is getting set to trial could be “the greatest drug of all time”.
“There can’t be a bigger prize than finding a treatment for dementia.”
The Perth business (ASX:NSB) has raised $6m in an oversubscribed initial public offer and plans to list on the ASX in the middle of next month. Leedman said the business was optimistic its drug, which has so far only be tested in rats, that it can regenerate neurons and then capture the attention of buyers.
“As we go through the clinical trial program, we will get the attention of big pharma, and they will buy us,” Mr Leedman said.
Cheers
Red bar
NSB
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
-0.005(12.8%) |
Mkt cap ! $5.639M |
Open | High | Low | Value | Volume |
3.7¢ | 3.7¢ | 3.4¢ | $21.49K | 608.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 7060 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 12035 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 26373 | 0.036 |
1 | 50000 | 0.035 |
1 | 230000 | 0.034 |
3 | 160000 | 0.033 |
1 | 200000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 175000 | 1 |
0.041 | 200000 | 1 |
0.042 | 25000 | 1 |
0.043 | 40000 | 1 |
0.045 | 20000 | 1 |
Last trade - 15.58pm 27/09/2024 (20 minute delay) ? |
NSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online